André Habel

1.2k total citations
12 papers, 977 citations indexed

About

André Habel is a scholar working on Virology, Epidemiology and Molecular Biology. According to data from OpenAlex, André Habel has authored 12 papers receiving a total of 977 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Virology, 6 papers in Epidemiology and 3 papers in Molecular Biology. Recurrent topics in André Habel's work include HIV Research and Treatment (6 papers), Herpesvirus Infections and Treatments (3 papers) and vaccines and immunoinformatics approaches (2 papers). André Habel is often cited by papers focused on HIV Research and Treatment (6 papers), Herpesvirus Infections and Treatments (3 papers) and vaccines and immunoinformatics approaches (2 papers). André Habel collaborates with scholars based in France, Austria and Germany. André Habel's co-authors include Steven Hagens, Udo Bläsi, Alexander von Gabain, Uwe von Ahsen, Karl-Erich Jäger, Elisabeth Sonnleitner, Susanne Wilhelm, Frank Rosenau, Duc Bui Minh and Åke Örtqvist and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Virology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

André Habel

12 papers receiving 945 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
André Habel France 10 372 315 268 211 204 12 977
Carly M. Bliss United Kingdom 14 402 1.1× 283 0.9× 99 0.4× 122 0.6× 272 1.3× 19 1.0k
Donata Sizemore United States 16 267 0.7× 261 0.8× 134 0.5× 153 0.7× 532 2.6× 24 1.1k
Jian-hua Zhou China 22 524 1.4× 240 0.8× 88 0.3× 170 0.8× 178 0.9× 66 1.1k
Reggie Y.C. Lo Canada 17 445 1.2× 123 0.4× 263 1.0× 127 0.6× 113 0.6× 48 1.0k
Sheena M. Loosmore Canada 16 224 0.6× 407 1.3× 67 0.3× 128 0.6× 332 1.6× 32 954
Maria Rita Fontana Italy 17 309 0.8× 269 0.9× 102 0.4× 84 0.4× 396 1.9× 21 1.1k
Stefan Fälker Germany 10 464 1.2× 195 0.6× 122 0.5× 153 0.7× 134 0.7× 12 936
Tobias Schlapp Germany 19 170 0.5× 144 0.5× 117 0.4× 138 0.7× 382 1.9× 29 991
Katsumi KUME Japan 23 252 0.7× 294 0.9× 258 1.0× 85 0.4× 91 0.4× 72 1.4k
César B. Gutiérrez‐Martín Spain 21 196 0.5× 148 0.5× 276 1.0× 86 0.4× 256 1.3× 78 1.3k

Countries citing papers authored by André Habel

Since Specialization
Citations

This map shows the geographic impact of André Habel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Habel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Habel more than expected).

Fields of papers citing papers by André Habel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André Habel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Habel. The network helps show where André Habel may publish in the future.

Co-authorship network of co-authors of André Habel

This figure shows the co-authorship network connecting the top 25 collaborators of André Habel. A scholar is included among the top collaborators of André Habel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André Habel. André Habel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Brandler, Samantha, Claude Ruffié, Chantal Combredet, et al.. (2013). A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus. Vaccine. 31(36). 3718–3725. 124 indexed citations
3.
Meinke, Andreas, Markus Hanner, Tamás Henics, et al.. (2007). Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies. The Journal of Experimental Medicine. 205(1). 117–131. 227 indexed citations
4.
Hagens, Steven, André Habel, & Udo Bläsi. (2006). Augmentation of the Antimicrobial Efficacy of Antibiotics by Filamentous Phage. Microbial Drug Resistance. 12(3). 164–168. 63 indexed citations
5.
Cardinaud, Sylvain, Arnaud Moris, Michèle Février, et al.. (2004). Identification of Cryptic MHC I–restricted Epitopes Encoded by HIV-1 Alternative Reading Frames. The Journal of Experimental Medicine. 199(8). 1053–1063. 65 indexed citations
6.
Hagens, Steven, André Habel, Uwe von Ahsen, Alexander von Gabain, & Udo Bläsi. (2004). Therapy of Experimental Pseudomonas Infections with a Nonreplicating Genetically Modified Phage. Antimicrobial Agents and Chemotherapy. 48(10). 3817–3822. 143 indexed citations
7.
Sonnleitner, Elisabeth, Steven Hagens, Frank Rosenau, et al.. (2003). Reduced virulence of a hfq mutant of Pseudomonas aeruginosa O1. Microbial Pathogenesis. 35(5). 217–228. 194 indexed citations
8.
Boretti, Felicitas S., Christian M. Leutenegger, Caroline N. Mislin, et al.. (2000). Protection against FIV challenge infection by genetic vaccination using minimalistic DNA constructs for FIV env gene and feline IL-12 expression. AIDS. 14(12). 1749–1757. 33 indexed citations
9.
Habel, André, Roger Le Grand, Frédéric Martinon, et al.. (2000). DNA vaccine protection against challenge with simian/human immunodeficiency virus 89.6 in rhesus macaques.. PubMed. 104. 101–5. 9 indexed citations
10.
11.
Girard, Marc, et al.. (1999). New prospects for the development of a vaccine against human immunodeficiency virus type 1. An overview. Comptes Rendus de l Académie des Sciences - Series III - Sciences de la Vie. 322(11). 959–966. 29 indexed citations
12.
Ryst, Elna van der, Tadashi Nakasone, André Habel, et al.. (1998). Study of the immunogenicity of different recombinant Mengo viruses expressing HIV1 and SIV epitopes. Research in Virology. 149(1). 5–20. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carly M. Bliss Breakdown of academic impact, for papers by Donata Sizemore Breakdown of academic impact, for papers by Jian-hua Zhou Breakdown of academic impact, for papers by Reggie Y.C. Lo Breakdown of academic impact, for papers by Sheena M. Loosmore Breakdown of academic impact, for papers by Maria Rita Fontana Breakdown of academic impact, for papers by Stefan Fälker Breakdown of academic impact, for papers by Tobias Schlapp Breakdown of academic impact, for papers by Katsumi KUME Breakdown of academic impact, for papers by César B. Gutiérrez‐Martín
Rankless by CCL
2026